These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 17883836)

  • 61. A novel paradigm for potential drug-targets discovery: quantifying relationships of enzymes and cascade interactions of neighboring biological processes to identify drug-targets.
    Chen L; Wang Q; Zhang L; Tai J; Wang H; Li W; Li X; He W; Li X
    Mol Biosyst; 2011 Apr; 7(4):1033-41. PubMed ID: 21270979
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Methods for predicting bacterial protein subcellular localization.
    Gardy JL; Brinkman FS
    Nat Rev Microbiol; 2006 Oct; 4(10):741-51. PubMed ID: 16964270
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Biochemical network-based drug-target prediction.
    Klipp E; Wade RC; Kummer U
    Curr Opin Biotechnol; 2010 Aug; 21(4):511-6. PubMed ID: 20554441
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Are MAP kinases drug targets? Yes, but difficult ones.
    Margutti S; Laufer SA
    ChemMedChem; 2007 Aug; 2(8):1116-40. PubMed ID: 17541990
    [TBL] [Abstract][Full Text] [Related]  

  • 65. ADME evaluation in drug discovery. 6. Can oral bioavailability in humans be effectively predicted by simple molecular property-based rules?
    Hou T; Wang J; Zhang W; Xu X
    J Chem Inf Model; 2007; 47(2):460-3. PubMed ID: 17381169
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Support vector machines approach for predicting druggable proteins: recent progress in its exploration and investigation of its usefulness.
    Han LY; Zheng CJ; Xie B; Jia J; Ma XH; Zhu F; Lin HH; Chen X; Chen YZ
    Drug Discov Today; 2007 Apr; 12(7-8):304-13. PubMed ID: 17395090
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A comparison of machine learning techniques for detection of drug target articles.
    Danger R; Segura-Bedmar I; Martínez P; Rosso P
    J Biomed Inform; 2010 Dec; 43(6):902-13. PubMed ID: 20688192
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Use of ligand based models for protein domains to predict novel molecular targets and applications to triage affinity chromatography data.
    Bender A; Mikhailov D; Glick M; Scheiber J; Davies JW; Cleaver S; Marshall S; Tallarico JA; Harrington E; Cornella-Taracido I; Jenkins JL
    J Proteome Res; 2009 May; 8(5):2575-85. PubMed ID: 19271732
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 3DS3 and 3DS5 3D-SHOTGUN meta-predictors in CAFASP3.
    Fischer D
    Proteins; 2003; 53 Suppl 6():517-23. PubMed ID: 14579341
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Biology calls the targets: combining RNAi and disease biology.
    van Es HH; Arts GJ
    Drug Discov Today; 2005 Oct; 10(20):1385-91. PubMed ID: 16253877
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Therapeutic targets: progress of their exploration and investigation of their characteristics.
    Zheng CJ; Han LY; Yap CW; Ji ZL; Cao ZW; Chen YZ
    Pharmacol Rev; 2006 Jun; 58(2):259-79. PubMed ID: 16714488
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Structural biology and drug discovery.
    Congreve M; Murray CW; Blundell TL
    Drug Discov Today; 2005 Jul; 10(13):895-907. PubMed ID: 15993809
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Drug-target interaction prediction by learning from local information and neighbors.
    Mei JP; Kwoh CK; Yang P; Li XL; Zheng J
    Bioinformatics; 2013 Jan; 29(2):238-45. PubMed ID: 23162055
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Screening the receptorome.
    Kroeze WK; Roth BL
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):41-6. PubMed ID: 16785269
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chemical-protein interactome and its application in off-target identification.
    Yang L; Wang KJ; Wang LS; Jegga AG; Qin SY; He G; Chen J; Xiao Y; He L
    Interdiscip Sci; 2011 Mar; 3(1):22-30. PubMed ID: 21369884
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Drug-domain interaction networks in myocardial infarction.
    Wang H; Zheng H; Azuaje F; Zhao XM
    IEEE Trans Nanobioscience; 2013 Sep; 12(3):182-8. PubMed ID: 23974657
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identifying and characterizing binding sites and assessing druggability.
    Halgren TA
    J Chem Inf Model; 2009 Feb; 49(2):377-89. PubMed ID: 19434839
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Investigating drug-target association and dissociation mechanisms using metadynamics-based algorithms.
    Cavalli A; Spitaleri A; Saladino G; Gervasio FL
    Acc Chem Res; 2015 Feb; 48(2):277-85. PubMed ID: 25496113
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Protein kinases in drug discovery and development.
    Hadari YR
    IDrugs; 2001 Dec; 4(12):1329-32. PubMed ID: 15931557
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Machine learning models for lipophilicity and their domain of applicability.
    Schroeter T; Schwaighofer A; Mika S; Laak AT; Suelzle D; Ganzer U; Heinrich N; Müller KR
    Mol Pharm; 2007; 4(4):524-38. PubMed ID: 17637064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.